Rick Santelli is standing by at the CME in Chicago. And uh Rick, take it away. Let's see the numbers.Yes. And there are a lot of numbers, so we're going to go slow. And let's start with well, let's start with durable goods, shall we.On durable good orders, we're expecting a number that's going to be somewhere in the vicinity of up 8 to 8 and a half% on a preliminary, not coming across the screen. So, we're going to switch gears. We're going to look at the trade balance minus 96.6% billion.So the good news t ...

24 June 2025 | 2:17PM CST China Solar Lower for longer Bottom line: Profitability inflection to be pushed out due to slower demand growth and long run normalized earnings to stay low, but still on track to reach a cyclical bottom in 2025E. We believe China's solar industry is on track to reach a cyclical bottom in 2025E with improving supply/demand balance on back of larger capex cut by Group 1 players, but mid-to-long run normalized profitability will likely stay low in our view, given demand growth slowdo ...

Investor Overview April 2025 Safe Harbor and Non-GAAP Financial Measures Note Regarding Forward-Looking Statements: 1 Certain statements and information included in this presentation are "forward-looking statements" under the Federal Private Securities Litigation Reform Act of 1995, including: our forecast; our outlook; our expectations regarding market trends and economic environment, such as rental demand, economic growth, challenging freight environment, weakening used vehicle sales and rental; our expec ...

Core Insights - Cue Biopharma, Inc. has received positive Pre-IND feedback from the FDA regarding its lead autoimmune asset, CUE-401, a first-in-class bispecific molecule designed to induce and expand regulatory T cells (Tregs) in vivo [1][2] - CUE-401 utilizes the combined activities of transforming growth factor beta (TGF-β) and a modified variant of interleukin 2 (IL-2) to potentially provide durable immune rebalance and tolerance for various autoimmune diseases [2][4] Company Overview - Cue Biopharma is a clinical-stage biopharmaceutical company focused on developing a novel class of therapeutic biologics that selectively engage and modulate disease-specific T cells for autoimmune disease treatment [1][8] - The company’s proprietary platform, Immuno-STAT™, aims to harness the body's intrinsic immune system without the adverse effects of broad systemic immune modulation [8] Product Details - CUE-401 is engineered to enhance the Treg induction capacity of TGF-β combined with IL-2 signaling, which is believed to improve the quality and stability of Tregs [5][6] - The design of CUE-401 allows for "conditional binding," which minimizes off-target activity and simplifies manufacturing processes [6] Mechanism of Action - CUE-401 acts as a master switch to convert autoreactive effector T cells into stable, induced T-regulatory cells (iTregs), establishing a 'tolerance positive feedback loop' that increases nonspecific Treg populations while reducing autoreactive T cells [7]

[Applause] [Music] [Applause] Hi everyone. I'm so excited to be here um and talk to you about something that's really close to my heart, gender narratives. I'm going to start with introducing you to my niece Eva and nephew Ari.About three years ago, when they were seven and four, I overheard a conversation between Eva and Ari where Eva told Ari, "Arri, you're so lucky to be a boy because when you grow up, you can be anything. But I'm not excited to grow up because I have to be a wife and I have to have a ba ...

U ovom iskrenom i nadahnjujućem govoru, Sonja Vasić, nas vodi kroz svoje životne faze - od detinjstva ispunjenog snovima, preko izazova i trijumfa u profesionalnoj košarkaškoj karijeri, do uloge majke, supruge i sportske liderke. Kroz lična iskustva, povrede, sumnje i velike preokrete, Sonja govori o važnosti balansa, autentičnosti i vrijednosti koje nas vode kroz odluke. Njena poruka je snažna - da ne moramo birati između porodice i karijere, snage i ranjivosti, ambicije i mira. Umesto toga, možemo i moram ...

方正证券发布研报称，刚果(金)作为全球钴供应主产国（2024年产量占比75.9%），其暂停钴出口4个月 的政策将显著打破市场供给过剩预期，政策出台后钴价已上涨14.5%至18.2万元/吨。基于对钴金属价格 的乐观预期，该行建议关注华友钴业（603799）、腾远钴业（301219）、寒锐钴业（300618）、洛阳钼 业（603993）等。 钴价处于历史底部位置，刚果(金)政府稳价意愿强烈 2月24日中国钴金属价格为15.9万元/吨，为2007年以来的底部位置。在刚果(金)禁止出口政策出台后， 截至2月27日，钴金属价格上涨14.5%至18.2万元/吨。考虑到刚果(金)政府声明将在3个月后对政策效果 进行评估，该行认为刚果(金)政府稳价、挺价意愿强烈。 出口禁令有望重塑钴金属过剩格局 该行认为2022年以来钴金属价格的持续下跌，一方面是三元正极材料的市占率下滑，特别是低镍高钴产 品的占有率下降导致需求增速不及预期。另一方面是由于铜价高企，刚果(金)铜产量快速提升，导致伴 生钴产量大幅增长。该行认为随着三元占比下滑趋势的减弱以及消费电子国补下需求复苏，将会使钴金 属需求恢复平稳增长。而出口禁令将显著减少钴金属流入量 ...

June 17, 2025 04:01 AM GMT North American Energy | North America Navigating Geopolitical Risks & Stronger Oil WTI has rallied ~20% in June alongside rising geopolitical risks. Near-term strength could continue, but prices are biased lower in 2H25 absent supply disruption. Post recent moves, we revisit views across the Energy Sector. From here, we remain selective with a defensive bias & prefer gas over oil. Key Takeaways The Extel Survey is now open. We would greatly appreciate your support for the Joy.Golu ...

[Applause] [Music] [Applause] true or false no one wants to work anymore this is a common refrain I've heard from business owners over the past 5 to 10 years especially over the last five you may have even said it yourself owners and managers are always looking for help especially in today's market and many struggle to find and retain good help and it is true employees have the absolute pick of the litter when it comes to their chosen jobs and careers so they won't apply for let alone stay at a job that doe ...

Proceeds will be used to repay debtRogers will maintain full operational control of its wireless network TORONTO, June 20, 2025 (GLOBE NEWSWIRE) -- Rogers Communications Inc. (TSX: RCI.A and RCI.B; NYSE: RCI) today announced it has closed its CDN$7 billion equity investment from funds managed by Blackstone, backed by leading Canadian institutional investors. Blackstone has acquired a non-controlling interest in a new Canadian subsidiary of Rogers that owns a portion of Rogers wireless backhaul transport inf ...